Business News
A ‘breadth of protection:’ Novavax’s newly-approved COVID vaccine arms the US with a new weapon against Omicron BA.5 subvariant

[ad_1]
Novavax says its vaccine prompted ‘broad immune responses’ against all COVID variants, including BA.5, in clinical data. Read More
[ad_2]
Source link